Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over.
Ward JO, Reinholdt LG, Motley WW, Niswander LM, Deacon DC, Griffin LB, Langlais KK, Backus VL, Schimenti KJ, O'Brien MJ, Eppig JJ, Schimenti JC. Ward JO, et al. Among authors: niswander lm. PLoS Genet. 2007 Aug;3(8):e139. doi: 10.1371/journal.pgen.0030139. Epub 2007 Jul 6. PLoS Genet. 2007. PMID: 17784788 Free PMC article.
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia.
Balestra T, Niswander LM, Bagashev A, Loftus JP, Ross SL, Chen RK, McClellan SM, Junco JJ, Bárcenas López DA, Rabin KR, Fry TJ, Tasian SK. Balestra T, et al. Among authors: niswander lm. Leukemia. 2024 Dec 16. doi: 10.1038/s41375-024-02493-3. Online ahead of print. Leukemia. 2024. PMID: 39681640
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.
Qin H, Yang L, Chukinas JA, Shah N, Tarun S, Pouzolles M, Chien CD, Niswander LM, Welch AR, Taylor N, Tasian SK, Fry TJ. Qin H, et al. Among authors: niswander lm. J Immunother Cancer. 2021 Sep;9(9):e003149. doi: 10.1136/jitc-2021-003149. J Immunother Cancer. 2021. PMID: 34531250 Free PMC article.
Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia.
Niswander LM, Loftus JP, Lainey É, Caye-Eude A, Pondrom M, Hottman DA, Iacobucci I, Mullighan CG, Jain N, Konopleva M, Cavé H, Baruchel A, Rohrlich PS, Tasian SK. Niswander LM, et al. Haematologica. 2021 Oct 1;106(10):2763-2767. doi: 10.3324/haematol.2021.278697. Haematologica. 2021. PMID: 34196168 Free PMC article. No abstract available.
Long-acting PGE2 and Lisinopril Mitigate H-ARS.
Saunders J, Niswander LM, McGrath KE, Koniski A, Catherman SC, Ture SK, Medhora M, Kingsley PD, Calvi LM, Williams JP, Morrell CN, Palis J. Saunders J, et al. Among authors: niswander lm. Radiat Res. 2021 Sep 1;196(3):284-296. doi: 10.1667/RADE-20-00113.1. Radiat Res. 2021. PMID: 34153091 Free PMC article.
15 results